Vita means life. It's also our platform for sharing the stories of biotech's promise to patients and public health.
CSL consists of CSL Behring, CSL Seqirus and CSL Vifor. Learn more by visiting each section.
Biotechnology leader CSL Behring offers the broadest range of quality plasma-derived and recombinant therapies in our industry.
Derived from the expression 'securing health for all of us', CSL Seqirus is one of the world's largest influenza vaccine providers.
R&D focuses its expertise on four strategic platforms: plasma protein technology; recombinant technology; cell and gene therapy; and vaccines technology.
One of our core values at CSL is Innovation. We support collaborative innovation through the endowment of awards and grants to researchers around the world.
As part of our broader sustainability strategy to build a more sustainable future, we've committed to a 40% reduction in absolute Scope 1 and 2 emissions by 2030.
Along with our sustainability strategy, CSL’s community contribution framework helps deliver on our Values and support execution of our 2030 strategy.
At CSL, Diversity, Equity, and Inclusion (DEI) is at the core of our mission and who we are. It fuels our innovation day in and day out.
Whether you are early in your college education or recently completed your degree, it's never too soon to consider CSL for your Promising Future!
Early research shows the potential of sa-mRNA “as the next generation of influenza vaccine technology,” says Roberta Duncan, …
this is the abstract
“Hear zebras not horses” started out as a call to action for doctors and made the zebra an icon for rare disease patients.
Sarah Sweat’s six-year career journey included hard work and a decision to stay focused on the patients who need plasma-deriv…
Take it outside even when it’s chilly, experts say, and reap benefits for your physical and mental health.
Package information for patients is moving to electronic formats, eliminating the need for paper inserts. But the complicated…
Both EURORDIS and the U.S. National Institutes of Health are offering virtual events in February that highlight research and …
A new, user-friendly guide – soon to be an app – helps sickle cell disease patients who are considering joining research tria…
University of Illinois’ Nicholas Wu wins Seqirus-supported award for vaccine research.
Americas
Asia Pacific
Middle East
Europe